Skip to main content
. 2023 Jul 27;14(7):476. doi: 10.1038/s41419-023-05958-y

Fig. 4. Establishment of a stably passaged cell line (MP) derived from c-MET/sgp53 HCC.

Fig. 4

A Western blotting analysis of lysates from normal liver and MP cells. B Cell viability analysis for MP cells treated with cabozantinib, niclosamide, and metformin. C Gross images of MP-derived xenografts from mice treated with cabozantinib, niclosamide, metformin, and vehicles. D Tumor volume of mice treated with cabozantinib and vehicles. D Tumor volume of mice treated with niclosamide, metformin, and vehicles. Data are shown as mean ± SD.